Is a switch to intravaginal metronidazole in order? Sean Henahan Newsletter Article 14 February 2013 Pages: 3 - 3
Use of thrombolytics predicted to increase in the elderly Newsletter Article 14 February 2013 Pages: 4 - 4
Improving cancer therapy with new delivery systems Gill Higgins Newsletter Article 14 February 2013 Pages: 5 - 6
Percutaneous absorption not the only hurdle for topical cyclosporin Newsletter Article 14 February 2013 Pages: 7 - 7
Butyrate offers hope for patients with β-globin disorders Newsletter Article 14 February 2013 Pages: 9 - 9
Treating Paget’s disease with tiludronic acid gives sustained effect Newsletter Article 14 February 2013 Pages: 9 - 9
Identifying crucial targets in the immuno-inflammatory cascade Stephen King Newsletter Article 14 February 2013 Pages: 11 - 11
Collagen provides a new option for urinary incontinence Newsletter Article 14 February 2013 Pages: 13 - 13
Nosocomial infections still a major challenge for institutions Newsletter Article 14 February 2013 Pages: 16 - 16
Bezafibrate may offer more than Maxepa® after cardiac transplantation Newsletter Article 14 February 2013 Pages: 18 - 18
Insulin swap not to blame for hypoglycaemic changes Newsletter Article 14 February 2013 Pages: 19 - 19
Cyclosporin cleared of role in post-transplant dyslipidaemia Newsletter Article 14 February 2013 Pages: 19 - 19
A mechanism for the post-MI benefits of nisoldipine Newsletter Article 14 February 2013 Pages: 20 - 20